SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParkmead Regulatory News (PMG)

Share Price Information for Parkmead (PMG)

Share Price is delayed by 15 minutes
Get Live Data
19.00    0.00 (0.00%)
Bid:
17.00
Ask:
21.00
Spread: 4.00 (23.529%)
Market Cap: £20.49m
PMG Live PriceLast checked at - London Stock Exchange

Intraday Parkmead Share Chart

Operational Update

22 Jul 2025 07:00

RNS Number : 9469R
Parkmead Group (The) PLC
22 July 2025
Β 

22 July 2025

Β 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Β 

Β 

The Parkmead Group plc

("Parkmead", "the Company" or "the Group")

Β 

Β 

Operational Update

Parkmead is pleased to report on the successful conclusion of all post-completion tasks in the sale of its UK offshore petroleum licences to Serica Energy plc, via the previously announced sale of its subsidiary Parkmead E&P Ltd, worth up to a potential Β£134 million to the Group.

The Company has retained 100% of its cash producing assets, namely its four producing onshore gas fields in the Netherlands and its onshore electricity producing wind farm in Scotland.

Parkmead now intends to focus its attention on the delivery of greener energy. Therefore the disposal of Parkmead E&P Ltd marks a significant step in recalibrating the Company's portfolio, rendering Parkmead well poised to capitalise on opportunities in renewables, with a view to driving future growth and generating value for shareholders.

Increased Financial Strength

Parkmead is in a strong financial position, with cash balances of approximately Β£13 million as at 30 June 2025. The Group has minimal outstanding debt of just Β£0.7 million, which remains from the development of our 100% owned and operated wind farm at Kempstone Hill.

In addition, Parkmead will be receiving additional deferred cash totalling Β£7.0 million, relating to the sale of its UK E&P subsidiary to Serica. This further cash comprises two payments of Β£3.1 million and Β£3.9 million, due on 27 February 2026 and 27 February 2027 respectively. These payments are firm and unconditional. There are further potential payments to Parkmead of up to Β£30 million and Β£90 million, conditional on future field development approvals on the Skerryvore and Fynn licences respectively, providing the Company and its shareholders with the potential opportunity to realise significant additional upside in the future.

Glenskinnan Renewable Energy Park

Parkmead continues to advance its stake in the Glenskinnan Renewable Energy Park, a major integrated renewables project being developed in partnership with Galileo Empower, a leading European renewable energy developer.

The integrated scheme is being designed to deliver up to 98 MW of wind generated electrical capacity across 14 turbines, alongside 20 MW of solar PV and 30 MW of battery storage. Parkmead's owned land at Pitreadie will accommodate over 50% of the combined installed capacity proposed in the planning application, making it a central component of the development.

Key milestones include:

- Initial public consultation, completed in April 2025

- Scheme design being finalised in 2H 2025

- Second public consultation scheduled for end of Q3 2025

- Section 36 planning application to be submitted to Scottish Government during Q4 2025

Parkmead and Galileo are currently finalising commercial arrangements ahead of the Section 36 application, with the project representing a significant step forward in the Group's renewable energy strategy.

Netherlands Natural Gas Fields

In the first half of 2025, Parkmead's Dutch fields delivered an average net production of 155 boe/d. A successful coiled-tubing water wash was completed at Geesbrug in March, resulting in production doubling on this asset. An unplanned shutdown of the Vries system impacted performance at Grolloo, with production now successfully reinstated.

A number of new drilling targets are being evaluated to boost future production. Our Dutch business benefited from stronger commodity market conditions. During the first half of 2025, realised gas sales pricing increased to €41.86/MWh from €38.16/MWh in the prior six months. These assets continue to provide reliable cash flow and growth potential which supports the Group's broader strategy.

Kempstone Hill Wind Farm

The Parkmead operated wind farm at Kempstone Hill continued to perform strongly through the first half of 2025. Over the last 12 months Parkmead has achieved and maintained an exceptionally high level of operational efficiency, in the range 96-99%. This demonstrates the reliability of the asset. The Group is continuing to assess the potential to expand the electricity production capability of the Kempstone Hill site, to make use of its excess grid capacity.

Corporate and Business Development

Parkmead is continuing to mature a range of high-impact investment and acquisition opportunities. These initiatives are aligned with the Group's strategy to grow and diversify its interests across international E&P and UK renewable energy projects.

Given that Parkmead will no longer be an offshore licence Operator in the North Sea, with all the regulatory aspects and operational demands that entails, we have reduced staff positions and reduced our office space by over 40%. After more than four years of excellent service as a non-executive director, Robert Finlay has left the board with immediate effect to focus on his other activities. We would like to thank Robert for his important contribution to the Group and wish him every success in the future. The Company is well advanced in its process to bring a further independent NED onboard and will provide an update in due course.

Β 

Parkmead's Executive Chairman, Tom Cross, commented:

"Parkmead has made strong progress across all elements of the business in the first half of 2025. We have completed the sale of our UK offshore-focused subsidiary, delivered solid operational performance from our onshore producing assets, advanced our flagship renewable energy project at Glenskinnan, and achieved a very healthy and robust financial position.

Our continued focus on strategic growth and efficiency ensures Parkmead is well positioned for the future."

Β 

The Parkmead Group plc

+44 (0) 1224 622200

Tom Cross (Executive Chairman)

Andrew Smith (Executive Director - Business Development)

Cavendish Capital Markets Limited

+44 (0) 20 7220 0500

Marc Milmo / Seamus Fricker - Corporate Finance

Iain MacArthur - Sales

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDPPUCPMUPAGMG
Date   Source Headline
6th Oct 20061:24 pmRNSDirectorate Change
4th Sep 20064:11 pmRNSDirectorate Change
10th Aug 200610:30 amRNSTrading Statement
30th Jun 20063:30 pmRNSCancellation of Share Premium
21st Jun 20064:43 pmRNSDirector/PDMR Shareholding
7th Jun 200612:30 pmRNSDirectorate Change
23rd May 20067:03 amRNSDirector shareholding
15th May 20064:23 pmRNSChange of Name
12th May 200612:13 pmRNSEGM Statement
26th Apr 20061:54 pmRNSCorrection to Announcement
19th Apr 20069:10 amRNSChange of Name
12th Apr 20067:00 amRNSChange of Adviser
5th Apr 20065:25 pmRNSDirector/PDMR Shareholding
5th Apr 200612:00 pmRNSFurther re Sale of Portfolio
31st Mar 20067:02 amRNSInterim Results
2nd Mar 20067:01 amRNSDirectorate Change
1st Mar 200612:14 pmRNSSAR 3 - Interregnum PLC
22nd Feb 200610:52 amRNSSAR 3 - Interregnum Plc
22nd Feb 20067:01 amRNSAcquisition
21st Feb 200612:26 pmRNSResult of EGM
16th Feb 20067:01 amRNSProposed Acquisition
2nd Feb 200610:05 amRNSDirectorate Change
30th Jan 20067:01 amRNSNotice of EGM
13th Jan 200611:03 amRNSDirectorate Change
21st Dec 20057:01 amRNSUpdate
20th Dec 20051:18 pmRNSResult of AGM
13th Dec 20051:24 pmRNSPortfolio Company Funding
24th Nov 20052:57 pmRNSBoard Appointment
27th Oct 20057:01 amRNSFinal Results
13th Oct 200511:55 amRNSNotice of Full Year Results
27th Sep 20057:00 amRNSAcquisition
18th Jul 20052:47 pmRNSDirector/PDMR Shareholding
3rd Jun 20057:00 amRNSITR Red-M IPO
3rd May 20057:00 amRNSAcquisition
27th Apr 20057:01 amRNSSubsidiary Company Merger
16th Mar 20057:00 amRNSAdvises on Sale of Chevin Ltd
14th Mar 20057:00 amRNSRe Agreement
25th Feb 20053:39 pmRNSHolding(s) in Company
24th Feb 20057:30 amRNSInterim Results
21st Feb 20055:15 pmRNSNotice of Results
28th Jan 20054:46 pmRNSHolding(s) in Company
27th Jan 20057:00 amRNSAcquisition & Trading Update
11th Jan 20059:00 amRNSStatement re appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.